Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yaniv Shilo is active.

Publication


Featured researches published by Yaniv Shilo.


Urology | 2010

Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery.

Orit Raz; Sonia Mendlovic; Yaniv Shilo; Dan Leibovici; Judith Sandbank; Arie Lindner; Amnon Zisman

OBJECTIVES To define the rate of positive surgical margins (PSMs) and analyze the outcome of patients with PSMs. The outcome and proper management of patients with positive PSMs during nephron sparing surgery (NSS) are questionable. In this study we define the clinical outcomes of PSMs at NSS and suggest management. METHODS Clinical records of 114 renal units who underwent open NSS for a renal mass between May 1995 and September 2005 were reviewed. RESULTS PSMs were suspected on frozen section in 17 of 114 renal units (15%). Tumors with suspected PSMs at frozen section were smaller (2.9 +/- 1.6) in comparison to those with negative surgical margins (3.4 +/- 1.8 cm) (P = .001). Nine of 17 (53%) cases underwent total nephrectomy (5 immediately, 4 delayed). In 4 (24%), immediate re-excision of the renal crater was performed. A total of 4 (24%) that were followed up clinically were with no evidence of disease. Therefore, in 13 of 17 (77%) cases, the presence of tumor cells at the remaining side of the kidney could be evaluated histologically. In 2 cases from the immediate response group, tumor cells were found in the side opposite to the resection. There was no residual tumor in any case subjected to delayed nephrectomy. At median follow-up of 71 months, 15 of 17 patients are alive and with no evidence of disease. Two patients died because of unrelated causes. The overall 5-year survival rate is 98.2% and there is no cancer-specific mortality. CONCLUSIONS The true PSM rate is in the range of 1.75%-5.26%. No disease progression or deaths attributable to renal cell carcinoma were associated with PSMs. Total nephrectomy should be avoided as a response to PSMs.


Urologic Oncology-seminars and Original Investigations | 2012

Testicular sparing surgery for small masses

Yaniv Shilo; Amnon Zisman; Orit Raz; Erez Lang; Simon Strauss; Judith Sandbank; Michael Segal; Yoram I. Siegel; Dan Leibovici

OBJECTIVES To determine the proportion of benign testicular lesions among candidates for testicular sparing surgery (TSS) and to assess the safety and efficacy of this procedure. METHODS AND MATERIALS Sixteen patients underwent surgical exploration for testicular tumors with TSS intent in our center. Surgery was performed via an inguinal approach with temporary cord occlusion and frozen section (FS) analysis of the lesions. Benign findings allowed for TSS, whereas cancer prompted total orchiectomy. RESULTS The lesions measured 8-25 mm in the largest diameter. Eleven of the 16 lesions were benign (69%) and TSS was accomplished in these cases. Complete concordance was observed between the results of FS and permanent sections. Of the 5 patients with cancer, 3 had pure seminoma, and embryonal carcinoma and teratoma were found in 1 patient, each. Surveillance was applied in 4 of these patients, and chemotherapy was used in the patient with embryonal carcinoma. With an average follow-up duration of 48 months, all are alive and free of disease. All 11 patients in whom TSS was accomplished had an uneventful postoperative course, and with an average follow-up duration of 28 months, 9 have normal scrotal physical examination and ultrasound, whereas 2 patients were lost to follow-up. CONCLUSIONS Sixty-nine percent of testicular lesions under 25 mm are benign. TSS is safe and effective in patients with small benign lesions. Cancer is reliably detected by FS, and testicular exploration is not associated with local or distant recurrence in any of our patients.


The Journal of Urology | 2013

Comparison of Lower Urinary Tract Symptoms Between Women with Detrusor Overactivity and Impaired Contractility, and Detrusor Overactivity and Preserved Contractility

Kobi Stav; Yaniv Shilo; Amnon Zisman; Arie Lindner; Dan Leibovici

PURPOSE We compared symptoms in women with detrusor overactivity with impaired contractility and women with detrusor overactivity who had preserved contractility. MATERIALS AND METHODS The study included 359 consecutive women with detrusor overactivity who underwent multichannel urodynamics at our department between 2009 and 2011. The women were divided into 2 groups, including 151 (42%) with detrusor overactivity and impaired contractility, and 208 (58%) with detrusor overactivity and preserved contractility. We compared the 2 groups. RESULTS Women with detrusor overactivity and impaired contractility were older (mean ± SD age 73.2 ± 17.3 vs 54.1 ± 20.7 years) with a higher frequency of diabetes mellitus (49% vs 31%, each p <0.001). The prevalence of previous urinary retention and recurrent cystitis was significantly higher in women with impaired contractility (7% vs 1%, p <0.01 and 22% vs 7%, p <0.001, respectively). Mean post-void residual urine was greater in the group with impaired contractility (89 ± 42 vs 21 ± 18 ml) and the mean maximal flow rate was lower (11 ± 6 vs 23 ± 5 ml per second, each p <0.001). The frequency of storage symptoms was similar in the 2 groups. However, voiding symptoms were more common in women with impaired contractility, including a slow stream in 69% vs 42%, an intermittent stream in 72% vs 26%, hesitancy in 35% vs 22%, straining in 84% vs 26%, terminal dribbling in 73% vs 42% and incomplete emptying in 71% vs 49% (p <0.001). CONCLUSIONS Women with detrusor overactivity and impaired contractility are older than women with detrusor overactivity and preserved detrusor contractility. Urinary retention and recurrent cystitis are more frequent in women with detrusor overactivity and impaired contractility, and voiding symptoms are significantly more common.


Urologic Oncology-seminars and Original Investigations | 2012

The predominance of benign histology in small testicular masses.

Yaniv Shilo; Amnon Zisman; Arie Lindner; Orit Raz; Simon Strauss; Yoram I. Siegel; Michael Segal; Judith Sandbank; Dan Leibovici

OBJECTIVES To evaluate the concordance between testicular tumor size and benign histology in order to identify a cut-off size, below which the rate of benign lesions would be highest. METHODS AND MATERIALS During the years 1995-2008, we performed 131 consecutive testicular operations for testicular tumors. Ten of these were testicular preserving surgery, whereas the other 121 patients had radical orchiectomy. We searched for the rate of benign lesions in the following 3 groups of tumor diameter: 10 mm or less, 11-20 mm, and greater than 20 mm. ROC analysis was used to find the optimal size cut-off below which the rate of benign lesions would be highest. RESULTS Benign lesions were found in 11 patients (8%), including epidermoid cyst (n = 4), Leydig cell tumor (n = 3), fibrosis (n = 1), adenomatoid tumor (n = 2), and 1 patient with a simple cyst. Small tumor size strongly correlated with benign histology. The mean diameter of benign vs. malignant lesions was 15 mm and 41 mm, respectively (P < 0.05). The rate of benign lesions in tumors with a diameter of 10 mm or less, 11-20 mm and greater than 20 mm was 50%, 17%, and 2%, respectively. Receiver Operating characteristic (ROC) analysis with 87% sensitivity and 83% specificity revealed a cut-off value of 18.5 mm tumor diameter below which the proportion of benign lesions was 38.5% compared with 2% above it (P < 0.05). CONCLUSIONS While benign lesions comprise only 8% of all testicular tumors, their proportion among small lesions is much higher. With a size cut-off of 18.5 mm, 38.5% of smaller lesions are benign. These findings support consideration of testicular exploration for small testicular lesions aiming at preservation rather than predetermined radical orchiectomy.


Urologic Oncology-seminars and Original Investigations | 2013

Is the diagnostic yield of prostate needle biopsies affected by prostate volume

Dan Leibovici; Yaniv Shilo; Orit Raz; Kobi Stav; Judith Sandbank; Michael Segal; Amnon Zisman

OBJECTIVES To determine the effect of prostate volume on the diagnostic yield of prostate biopsies. MATERIALS AND METHODS 155 consecutive patients underwent 12-core transrectal ultrasound guided needle biopsies. Data were collected prospectively on age, serum PSA, digital rectal examination (DRE), previous prostate biopsies, prostate volume and pathologic result. Univariate and multivariate logistic regressions were undertaken to determine the effect of prostate volume on the risk for a positive biopsy. RESULTS 45 patients (29%) were diagnosed with cancer. The median patient age was 63 (range 48-82) years, the median PSA level was 6.7 ng/ml (0.5-156 ng/ml), and the median prostate volume was 57 ml (16-273 ml). 42 patients (27%) had an abnormal DRE and 51 (33%) had undergone previous prostate biopsies. Positive biopsy rates were 39%, 33%, and 14% for prostate volume below 46 ml, between 45 and 73 ml, and above 72 ml, respectively. Univariate analysis showed that age, serum PSA, DRE and prostate volume were all associated with a positive biopsy. Multivariate analysis adjusted for age, PSA and DRE showed a significant risk increase for a positive biopsy in smaller prostates. (OR = 5.6 95% CI 1.75-17.89; and 8.86 95% CI 2.72-28.82, for prostate volume between 45 and 72 ml and below 45 ml, respectively). CONCLUSION The diagnostic yield of prostate biopsies is significantly lower in large prostates. As the result the standard 12-core biopsy may be insufficient for the diagnosis of cancer in large prostates.


The Journal of Urology | 2008

THE INCIDENCE OF LARGE (>4 CM) BENIGN RENAL MASSES

Orit Raz; Sonia Mendlovic; Yaniv Shilo; Dan Leibovici; Judith Sandbank; Arie Lindner; Amnon Zisman

CONCLUSIONS: Large renal masses are not necessarily malignant. Large benign renal masses are not uncommon (10-20%). This data, justify reconsideration the role of preoperative biopsy of renal mass, since according to our data, if pre-operative tissue diagnosis existed it was possible to save 12 renal units (15.5%) as well to prevent warm renal ischemia in additional 18 cases (20%) that underwent partial nephrectomy, for lesions > 4cm in diameter.


Israel Medical Association Journal | 2013

Hyperbaric oxygen therapy for hemorrhagic radiation cystitis.

Yaniv Shilo; Shay Efrati; Zvi Simon; Avishay Sella; Eliahu Gez; Eyal Fenig; Mark Wygoda; Arie Lindner; Gregori Fishlev; Kobi Stav; Amnon Zisman; Yoram I. Siegel; Dan Leibovici


Israel Medical Association Journal | 2007

Late Migration of a Retained Bullet into the Urinary Bladder Presenting with Acute Urinary Retention

Orit Raz; Yaniv Shilo; Kobi Stav; Dan Leibovici


Israel Medical Association Journal | 2013

How accurate is our clinical prediction of "minimal prostate cancer"?

Dan Leibovici; Sergey Shikanov; Ofer N. Gofrit; Gregory P. Zagaja; Yaniv Shilo; Arieh L. Shalhav


The Journal of Urology | 2009

IS FAMILY HISTORY ASSOCIATED WITH PELVIC ORGAN PROLAPSE IN YOUNG WOMEN

Yaniv Shilo; Kobi Stav; Genadi Bitman; Arie Lindner; Eyal Schiff; Menachem Alcalay

Collaboration


Dive into the Yaniv Shilo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dan Leibovici

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dan Leibovici

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yoram I. Siegel

Houston Methodist Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge